Search results for : igf1r - Cancerrxgene - Genomics of Drug Sensitivity in Cancer

Search Results for: igf1r

Drugs (11)

Name	Synonyms	Targets	Target Pathway	PubCHEM	Datatset	Sample size	Screening site
BMS-536924	BMS 536924	IGF1R, IR	IGF1R signaling	10390396	GDSC1	396	MGH
BMS-536924	BMS 536924	IGF1R, IR	IGF1R signaling	10390396	GDSC1	909	SANGER
BMS-536924	BMS 536924	IGF1R, IR	IGF1R signaling	10390396	GDSC2	958	SANGER
BMS-754807	BMS754807, BMS 754807	IGF1R, IR	RTK signaling	24785538	GDSC1	865	MGH
BMS-754807	BMS-754807	IGF1R, IR	IGF1R signaling		GDSC2	949	SANGER
GSK1904529A	GSK-1904529A, GSK 1904529A	IGF1R, IR	RTK signaling	25124816	GDSC1	870	MGH
GSK1904529A	GSK-1904529A, GSK 1904529A	IGF1R, IR	IGF1R signaling	25124816	GDSC2	965	SANGER
IGF1R_3801	SN1051640224, IGF1R_3801	IGFR1	IGF1R signaling		GDSC2	716	SANGER
Linsitinib	OSI-906, ASP-7487	IGF1R	IGF1R signaling	11640390	GDSC1	867	MGH
Linsitinib	OSI-906, ASP-7487	IGF1R	IGF1R signaling	11640390	GDSC2	966	SANGER
NVP-ADW742	NVP ADW742, NVPADW742	IGF1R	IGF1R signaling	9825149	GDSC2	958	SANGER

The Genomics of Drug Sensitivity in Cancer Project is a collaboration between the Cancer Genome Project at the Wellcome Sanger Institute (UK) and the Center for Molecular Therapeutics, Massachusetts General Hospital Cancer Center (USA). This work is funded by Wellcome.

Users have a non-exclusive, non-transferable right to use data files for internal proprietary research and educational purposes, including target, biomarker and drug discovery. Excluded from this licence are use of the data (in whole or any significant part) for resale either alone or in combination with additional data/product offerings, or for provision of commercial services.
Please note: The data files are experimental and academic in nature and are not licensed or certified by any regulatory body. Genome Research Limited provides access to data files on an “as is” basis and excludes all warranties of any kind (express or implied).